Publicaciones en las que colabora con MARÍA JOSÉ OTERO LÓPEZ (24)

2023

  1. Validation and clinical evaluation of an ultra-performance liquid chromatography with ultraviolet detector method for plasma quantification of micafungin

    Annals of Clinical Biochemistry, Vol. 60, Núm. 3, pp. 191-198

2022

  1. External evaluation of population pharmacokinetic models of imatinib in adults diagnosed with chronic myeloid leukaemia

    British Journal of Clinical Pharmacology, Vol. 88, Núm. 4, pp. 1913-1924

  2. Long-term effectiveness and pharmacokinetics of the infliximab biosimilar CT-P13 after switching from the originator during the treatment of inflammatory bowel disease

    European Journal of Hospital Pharmacy, Vol. 29, Núm. 4, pp. 222-227

  3. Population pharmacokinetics of a posaconazole tablet formulation in transplant adult allogeneic stem cell recipients

    European Journal of Pharmaceutical Sciences, Vol. 168

2018

  1. Age as a Factor of Differentiation in Predictive Models of Valproic Acid Pharmacokinetics

    1st Global Congress of Pharmacy Faculties. Innovation in Pharmacy: Advances and Perspectives. September 24-28th, Salamanca, Spain 2018

2008

  1. Population Pharmacokinetics of Lamotrigine with Data from Therapeutic Drug Monitoring in German and Spanish Patients with Epilepsy

    Therapeutic Drug Monitoring, Vol. 30, Núm. 4, pp. 483-489

  2. Population pharmacokinetics of lamotrigine with data from therapeutic drug monitoring in german and spanish patients with epilepsy

    Therapeutic Drug Monitoring, Vol. 30, Núm. 4, pp. 483-489

2004

  1. Iniciación de un programa de monitorización de lamotrigina en pacientes epilépticos

    Atencion Farmaceutica, Vol. 6, Núm. 2, pp. 97-101

2003

  1. Seguridad de medicamentos. Prevención de errores de medicación

    Farmacia Hospitalaria, Vol. 27, Núm. 2, pp. 121-126

  2. Seguridad de medicamentos. Prevención de errores de medicación

    Farmacia Hospitalaria, Vol. 27, Núm. 6, pp. 396-400

2002

  1. Seguridad de medicamentos: Prevención de errores de medicación

    Farmacia Hospitalaria, Vol. 26, Núm. 6, pp. 381-385

2001

  1. Farmacocinética de poblaciones: Una aproximación a la optimización del tratamiento con antimicrobianos

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 19, Núm. 5, pp. 219-228

  2. Sensibilizacíon a benzodiacepinas

    Alergologia e Inmunologia Clinica

1999

  1. Population estimation of valproic acid clearance in adult patients using routine clinical pharmacokinetic data

    Biopharmaceutics and Drug Disposition, Vol. 20, Núm. 5, pp. 233-240

  2. Valproate population pharmacokinetics in children

    Journal of Clinical Pharmacy and Therapeutics, Vol. 24, Núm. 1, pp. 73-80

1997

  1. Carbamazepine population pharmacokinetics in children: Mixed-effect models

    Therapeutic Drug Monitoring, Vol. 19, Núm. 2, pp. 132-139

1988

  1. TDM OF THEOPHYLLINE—COMPLIANCE EVALUATION

    Journal of Clinical Pharmacy and Therapeutics, Vol. 13, Núm. 4, pp. 273-280

  2. Theophylline monitoring and noncompliance in chronic bronchial asthma.

    Drug intelligence & clinical pharmacy

1987

  1. Determination of plasma theophylline levels using a new analytical technique

    Farmacia Clinica, Vol. 4, Núm. 7 (528-530)+, pp. 532

1986

  1. Pleural fluid levels of cefoxitin in patients with renal impairment

    International Journal of Clinical Pharmacology Therapy and Toxicology, Vol. 24, Núm. 9, pp. 485-489